Trials / Completed
CompletedNCT00480610
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
Clinical Study on Tacrolimus Ointment Over the Long-term. "CONTROL Study - Adults"
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 226 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Long-term tacrolimus ointment based regimen comprising of up to 6 weeks of initial twice daily treatment and subsequent twice weekly prophylactic application can effectively treat active lesions of atopic dermatitis and prevent delay \& reduce flares
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus ointment | Topical application |
| DRUG | Placebo ointment | Topical application |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2007-05-31
- Last updated
- 2014-09-18
Locations
22 sites across 13 countries: Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00480610. Inclusion in this directory is not an endorsement.